A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment
S. Cruz-Gil, R. Sanchez-Martinez, S. Wagner-Reguero, D. Stange, S. Schölch, K. Werner, A. Ramirez de Molina
The paper assesses Metformin's effects on CRC-like organoids, finding it downregulates ACSL4 and reduces stem cell markers more effectively in early stages than 5-FU.
bioRxiv · Nov 5, 2018Cancer Biology